Back

VVMF wins TGA GMP licence for Sydney viral-vector facility

Verifying
  • VVMF received a TGA licence to manufacture therapeutic goods at its Sydney facility.
  • The licence covers replication-incompetent viral vectors, sterile APIs, Medicinal Products and QC testing.
  • The Westmead facility supports Australian and international advanced-therapy developers with local manufacturing services.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
VVMF wins TGA GMP licence for Sydney viral-vector facility - CoinPost Terminal